美国aTyr Pharma, Inc.
aTyr Pharma, Inc. 是致力于研发全新类别生物制剂的生物制药公司。
aTyr Pharma 新型生物治疗药物的研发工具包括 tRNA 合成酶系列中的新型蛋白质片段，这些蛋白质片段拥有通常与 tRNA 合成酶相关的蛋白质合成功能截然不同的细胞信号传递功能。这些蛋白片段，或称为”resectins”，正被开发成治疗血液异常、神经退化性疾病、炎症、心血管疾病和新陈代谢功能失调的新颖疗法

aTyr Pharma discovers and develops protein therapeutics for human diseases. We are building a comprehensive intellectual property portfolio across a family of proteins and their biologically active components.

These biologics have therapeutic potential across a wide range of disease areas including vascular, inflammation, oncology, metabolic, neurologic and dermatologic disorders. Two novel biologics are currently in pre-clinical development.

aTyr Pharma also has established domestic and international collaborative corporate and academic partners for pre-clinical research and development. aTyr Pharma will select products from the development pipeline for internal development, corporate partnerships, and out-licensing.